The significant progress made in successfully treating many common cancers is being undermined by the growing threat of antimicrobial resistance (#AMR). AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness, and death. #StandUpToCancer is joining World Health Organization and Union for International Cancer Control (UICC) to improve awareness and understanding of AMR this #WorldAMRAwarenessWeek. Learn more at https://bit.ly/4fQJcG2.
Stand Up To Cancer’s Post
More Relevant Posts
-
Our DxConnect NTD test directory shows that there are 218 commercially available assays for the following neglected tropical diseases (NTDs): Chagas disease, schistosomiasis, lymphatic filariasis, visceral leishmaniasis (VL), leprosy, onchocerciasis, and mycetoma. However, although the total number of tests seems high, significant gaps remain in diagnostic accessibility, suitability for low-resource settings, performance, and regulatory approval. For instance, molecular point-of-care tests are available only for VL and leprosy. Our platform also shows huge diagnostic gaps for onchocerciasis and mycetoma. Discover further insights on NTD tests in our DxConnect dashboard: https://lnkd.in/eMn6vFQp #WorldNTDDay
-
-
Tuberculosis (TB) is preventable and treatable, Watch this video to understand the symptoms, diagnostic methods, and importance of early detection. With advanced diagnostic tests like X-ray chest, Sputum AFB, Mantoux, TB Gold Test, and PCR (Molecular), Tuberculosis (TB) can be detected and treated effectively. Don’t wait—get tested if you suspect symptoms. Together, we can fight TB and ensure healthier lives. Don’t ignore the signs—get tested today. World Health Organization Dr. Saami Shahbazker Molbio Diagnostics Agappe Diagnostics Ltd Dr. Shital Ulhas Vasave
-
Eurofins Viracor has launched an innovative quantitative PCR assay for the detection of Trypanosoma cruzi (T. cruzi), the parasitic cause of Chagas disease. More than 5 million people worldwide have Chagas disease, according to the World Health Organisation. Chagas disease often goes undiagnosed due to its asymptomatic nature in its early stages, and the limitations of traditional diagnostic methods. This new test from Eurofins Viracor is a crucial tool for the accurate detection of T. cruzi infection, particularly among organ transplant recipients or immunocompromised patients. The launch of this test underscores Eurofins Viracor's commitment to improving diagnostic solutions for underserved conditions such as Chagas disease, and ultimately, patient outcomes. #Eurofins #Chagas #OrganTransplant #TestingForLife #Viracor
-
-
Did you know that infections are often the primary cause of death in cancer patients? 🤔 Dr. Leong Hoe Nam from Rophi Clinic, an esteemed specialist in infectious diseases, explains why infections are so tough and what measures are taken to tackle bacteria in the system. #CancerCare #InfectiousDiseases #doctors
-
Antibody levels can help inform future #COVID19 infection risk and optimize booster scheduling. This article by IQVIA’s Caroline Tai, Miriam Haviland, Christina Mack, Rachel McFarland Lucia, Ph.D. and industry colleagues explores how an integrated evidence hub of health, lab, and genomic sequencing data from the NBA was used to evaluate the relationship between antibody levels and risk of #COVID19 infection – contributing to an understanding of real world effectiveness and global public health. https://bit.ly/3WAsrZq
-
-
Antibody levels can help inform future #COVID19 infection risk and optimize booster scheduling. This article by IQVIA’s Caroline Tai, Miriam Haviland, Christina Mack, Rachel McFarland Lucia, Ph.D. and industry colleagues explores how an integrated evidence hub of health, lab, and genomic sequencing data from the NBA was used to evaluate the relationship between antibody levels and risk of #COVID19 infection – contributing to an understanding of real world effectiveness and global public health. https://bit.ly/3V9Eb3I
-
Eurofins Viracor has launched an innovative #Quantitative #PCRAssay for the detection of #Trypanosoma #cruzi (T. cruzi), the parasitic cause of #ChagasDisease. More than 5 million people worldwide have Chagas disease, according to the World Health Organization(#WHO). Chagas disease often goes undiagnosed due to its asymptomatic nature in its early stages, and the limitations of traditional diagnostic methods. This new test from Eurofins Viracor is a crucial tool for the accurate detection of T. cruzi infection, particularly among organ transplant recipients or #Immunocompromised patients. The launch of this test underscores Eurofins Viracor's commitment to improving #DiagnosticSolutions for underserved conditions such as Chagas disease, and ultimately, patient outcomes. #Eurofins #Viracor #Chagas #OrganTransplant #TestingForLife
Eurofins Viracor has launched an innovative quantitative PCR assay for the detection of Trypanosoma cruzi (T. cruzi), the parasitic cause of Chagas disease. More than 5 million people worldwide have Chagas disease, according to the World Health Organisation. Chagas disease often goes undiagnosed due to its asymptomatic nature in its early stages, and the limitations of traditional diagnostic methods. This new test from Eurofins Viracor is a crucial tool for the accurate detection of T. cruzi infection, particularly among organ transplant recipients or immunocompromised patients. The launch of this test underscores Eurofins Viracor's commitment to improving diagnostic solutions for underserved conditions such as Chagas disease, and ultimately, patient outcomes. #Eurofins #Chagas #OrganTransplant #TestingForLife #Viracor
-
-
The VEGF/ VEGFR axis plays a crucial role in blood vessel formation and has significant implications in health and disease. Its role in angiogenesis makes it a key target in treating various cancers, eye diseases, and other conditions where abnormal blood vessel formation is a concern. Discover our VEGFR reporter cell line: https://hubs.ly/Q02Pmh1m0 #drugdiscovery #VEGF #VEGFR
-
-
Vice President, Commercial at Eurofins Viracor ★ Purveyor of Peak Performance and Enhanced Value through Authentic Leadership, Strategic Focus and WaaS ★ Tech Sherpa in Genomic, Genetic and Molecular Medicine
🚨 Big news from Eurofins Viracor‼️ We’ve just rolled out an innovative quantitative PCR assay to detect Trypanosoma cruzi (T. cruzi), the parasitic culprit behind Chagas disease. 🧬🔬 🌎 With over 5 million people affected globally (thanks, World Health Organization for the stats!), Chagas disease often slips under the radar due to its sneaky, symptom-free early stages and aged diagnostic methods. ⚡ Enter Eurofins Viracor’s new test: a game-changer for precise detection of T. cruzi, especially for organ transplant recipients and immunocompromised patients who need it most. 💪 This launch is more than just innovation—it’s a testament to our mission of improving lives and building assays for underserved conditions like Chagas disease and transforming patient care. #Eurofins #ChagasDisease #HealthcareInnovation #Viracor #TestingForLife
Eurofins Viracor has launched an innovative quantitative PCR assay for the detection of Trypanosoma cruzi (T. cruzi), the parasitic cause of Chagas disease. More than 5 million people worldwide have Chagas disease, according to the World Health Organisation. Chagas disease often goes undiagnosed due to its asymptomatic nature in its early stages, and the limitations of traditional diagnostic methods. This new test from Eurofins Viracor is a crucial tool for the accurate detection of T. cruzi infection, particularly among organ transplant recipients or immunocompromised patients. The launch of this test underscores Eurofins Viracor's commitment to improving diagnostic solutions for underserved conditions such as Chagas disease, and ultimately, patient outcomes. #Eurofins #Chagas #OrganTransplant #TestingForLife #Viracor
-
-
Today marks a global initiative to raise awareness about viral hepatitis, promote prevention, and encourage testing & treatment. Five main strains of the hepatitis virus are responsible for most cases. Hepatitis B and C are the most common, accounting for over 90% of hepatitis-related deaths. Chronic hepatitis infections can lead to severe health issues, including cirrhosis, liver cancer, and liver failure. According to Arkansas Department of Health statistics, new Arkansas cases of Hepatitis C have decreased from 750 in Aug 2019 to just three new cases in February 2024! #WorldHepatitisDay
-
